Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 20;14(5):176-179.
doi: 10.1002/cld.864. eCollection 2019 Nov.

A Practical Approach to Polycystic Liver Disease

Affiliations
Review

A Practical Approach to Polycystic Liver Disease

Armani Patel et al. Clin Liver Dis (Hoboken). .

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/14-5-reading-patel a video presentation of this article http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/14-5-interview-patel the interview with the author.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Gigot classification for PLD. Type I is characterized by a liver that has <10 large (>10 cm) cysts. Type II is characterized by diffuse parenchymal involvement by multiple medium‐sized cysts with large areas of noncystic parenchyma. Type III is characterized by large numbers of small‐ and medium‐sized cysts spread diffusely throughout the parenchyma with only minimal, normal areas.5
Figure 2
Figure 2
Algorithm for the medical and surgical management of PLD. Conservative management is indicated for patients who are asymptomatic; treatment is indicated only for patients with symptoms. Adapted with permission from Clinical Gastroenterology and Hepatology.2 Copyright 2017, Elsevier.

References

    1. Van Aerts RM, Van de Laarschot LF, Banales JM, et al. Clinical management of polycystic liver disease. J Hepatol 2018;68:827‐837. - PubMed
    1. Mikolajczyk AE, Te HS, Chapman AB. Gastrointestinal manifestations of autosomal‐dominant polycystic kidney disease. Clin Gastroenterol Hepatol 2017;15:17‐24. - PubMed
    1. Chapman AB, Devuyst O, Eckardt K‐U, et al. Autosomal‐dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015;88:17‐27. - PMC - PubMed
    1. Cnossen WR, Drenth JPH. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Orphanet J Rare Dis 2014;9:69. - PMC - PubMed
    1. Abu‐Wasel B, Walsh C, Keough V, et al. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases. World J Gastroenterol 2013;19:5775‐5786. - PMC - PubMed